Literature DB >> 15115878

Alpha 1-antitrypsin deficiency. 3: Clinical manifestations and natural history.

M Needham1, R A Stockley.   

Abstract

A review of the clinical manifestations of alpha(1)-antitrypsin (AAT) deficiency, including lung disease and liver disease, and risk factors affecting the rate of decline in lung function in AAT deficient patients.

Entities:  

Mesh：

Year:  2004        PMID： 15115878      PMCID： PMC1746985          DOI： 10.1136/thx.2003.006510

Source DB:  PubMed          Journal:  Thorax        ISSN： 0040-6376            Impact factor:   9.139


  66 in total

1.  Occupational exposure risks in individuals with PI*Z alpha(1)-antitrypsin deficiency.

Authors:  A S Mayer; J K Stoller; B Bucher Bartelson; A James Ruttenber; R A Sandhaus; L S Newman
Journal:  Am J Respir Crit Care Med       Date:  2000-08       Impact factor: 21.405

2.  PULMONARY EMPHYSEMA AND ALPHA1-ANTITRYPSIN DEFICIENCY.

Authors:  S ERIKSSON
Journal:  Acta Med Scand       Date:  1964-02

3.  Evidence for excessive bronchial inflammation during an acute exacerbation of chronic obstructive pulmonary disease in patients with alpha(1)-antitrypsin deficiency (PiZ).

Authors:  A T Hill; E J Campbell; D L Bayley; S L Hill; R A Stockley
Journal:  Am J Respir Crit Care Med       Date:  1999-12       Impact factor: 21.405

4.  Environmental correlates of impaired lung function in non-smokers with severe alpha 1-antitrypsin deficiency (PiZZ).

Authors:  E Piitulainen; G Tornling; S Eriksson
Journal:  Thorax       Date:  1998-11       Impact factor: 9.139

5.  Distribution of alpha(1)-antitrypsin alleles in patients with bronchiectasis.

Authors:  A Cuvelier; J F Muir; M F Hellot; D Benhamou; J P Martin; J Bénichou; R Sesboüé
Journal:  Chest       Date:  2000-02       Impact factor: 9.410

6.  Normal diffusing capacity in patients with PiZ alpha(1)-antitrypsin deficiency, severe airflow obstruction, and significant radiographic emphysema.

Authors:  J S Wilson; J R Galvin
Journal:  Chest       Date:  2000-09       Impact factor: 9.410

7.  Physiological and radiological characterisation of patients diagnosed with chronic obstructive pulmonary disease in primary care.

Authors:  C O'Brien; P J Guest; S L Hill; R A Stockley
Journal:  Thorax       Date:  2000-08       Impact factor: 9.139

8.  Augmentation therapy reduces frequency of lung infections in antitrypsin deficiency: a new hypothesis with supporting data.

Authors:  J Lieberman
Journal:  Chest       Date:  2000-11       Impact factor: 9.410

9.  Decline in FEV1 related to smoking status in individuals with severe alpha1-antitrypsin deficiency (PiZZ).

Authors:  E Piitulainen; S Eriksson
Journal:  Eur Respir J       Date:  1999-02       Impact factor: 16.671

10.  Effect of environmental and clinical factors on lung function and respiratory symptoms in adolescents with alpha1-antitrypsin deficiency.

Authors:  E Piitulainen; T Sveger
Journal:  Acta Paediatr       Date:  1998-11       Impact factor: 2.299
View more
  28 in total

1.  Simultaneous phenotyping and quantification of α-1-antitrypsin by liquid chromatography-tandem mass spectrometry.

Authors:  Yuhong Chen; Melissa R Snyder; Yi Zhu; Linda J Tostrud; Linda M Benson; Jerry A Katzmann; H Robert Bergen
Journal:  Clin Chem       Date:  2011-06-02       Impact factor: 8.327

Review 2.  Neutrophil elastase, proteinase 3, and cathepsin G as therapeutic targets in human diseases.

Authors:  Brice Korkmaz; Marshall S Horwitz; Dieter E Jenne; Francis Gauthier
Journal:  Pharmacol Rev       Date:  2010-12       Impact factor: 25.468

3.  Rapid and inexpensive detection of alpha1-antitrypsin deficiency-related alleles S and Z by a real-time polymerase chain reaction suitable for a large-scale population-based screening.

Authors:  Marcin P Kaczor; Marek Sanak; Andrew Szczeklik
Journal:  J Mol Diagn       Date:  2007-02       Impact factor: 5.568

4.  Genotypes and serum concentrations of human alpha-1-antitrypsin "P" protein variants in a clinical population.

Authors:  Joshua A Bornhorst; Fernanda R O Calderon; Melinda Procter; Wei Tang; Edward R Ashwood; Rong Mao
Journal:  J Clin Pathol       Date:  2007-10       Impact factor: 3.411

5.  Smoking and the incidence of asthma during adolescence: results of a large cohort study in Germany.

Authors:  J Genuneit; G Weinmayr; K Radon; H Dressel; D Windstetter; P Rzehak; C Vogelberg; W Leupold; D Nowak; E von Mutius; S K Weiland
Journal:  Thorax       Date:  2006-03-14       Impact factor: 9.139

Review 6.  The Genetics of Pneumothorax.

Authors:  Philip M Boone; Rachel M Scott; Stefan J Marciniak; Elizabeth P Henske; Benjamin A Raby
Journal:  Am J Respir Crit Care Med       Date:  2019-06-01       Impact factor: 21.405

7.  [Alpha1-antitrypsin deficiency in Austria: analysis of the Austrian Alpha1-international-registry database].

Authors:  Florian Huber; Karin Schmid-Scherzer; Felix Wantke; Sophie Frantal; Meinhard Kneussl
Journal:  Wien Klin Wochenschr       Date:  2010-07-14       Impact factor: 1.704

Review 8.  Neutrophil proteinase 3 and dipeptidyl peptidase I (cathepsin C) as pharmacological targets in granulomatosis with polyangiitis (Wegener granulomatosis).

Authors:  Brice Korkmaz; Adam Lesner; Stephanie Letast; Yassir K Mahdi; Marie-Lise Jourdan; Sandrine Dallet-Choisy; Sylvain Marchand-Adam; Christine Kellenberger; Marie-Claude Viaud-Massuard; Dieter E Jenne; Francis Gauthier
Journal:  Semin Immunopathol       Date:  2013-02-06       Impact factor: 9.623

Review 9.  Genetics of chronic obstructive pulmonary disease.

Authors:  Carola Seifart; Alexandra Plagens
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2007

10.  Chronic obstructive pulmonary disease: towards pharmacogenetics.

Authors:  Alice M Wood; See Ling Tan; Robert A Stockley
Journal:  Genome Med       Date:  2009-11-30       Impact factor: 11.117
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.